Stellanova Therapeutics

Stellanova Therapeutics is a privately held biotechnology company located in Houston, Texas. Founded with a small team of three employees, the company has generated $2.5 million in revenue. Stellanova Therapeutics focuses on developing innovative cancer therapies. Their approach centers on targeting cancer-associated fibroblasts (CAFs), specifically a subtype called stellate cells, which play a crucial role within the tumor microenvironment. By disrupting the interactions between CAFs and cancer cells, Stellanova aims to both directly attack the cancer and enhance the effectiveness of existing treatments like chemotherapy and immunotherapy. The company's research is rooted in groundbreaking discoveries made by Dr. Rosa Hwang's lab at MD Anderson Cancer Center. This foundation has allowed Stellanova to develop a novel strategy for cancer treatment, one that holds the potential to significantly improve patient outcomes. For more information about Stellanova Therapeutics and their groundbreaking approach to cancer treatment, please visit their website at stellanovatx.com.